HomeADAP • NASDAQ
Adaptimmune Therapeutics PLC - ADR
$1.58
After Hours:
$1.55
(1.90%)-0.030
Closed: Mar 28, 5:23:11 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$1.58
Day range
$1.53 - $1.65
Year range
$0.42 - $2.05
Market cap
389.98M USD
Avg Volume
1.85M
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
231.00K-97.91%
Operating expense
-76.42M16.71%
Net income
-47.92M-63.82%
Net profit margin
-20.74K-7,720.87%
Earnings per share
-0.24-33.33%
EBITDA
-46.98M-99.87%
Effective tax rate
1.35%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
146.94M-28.18%
Total assets
282.62M-14.08%
Total liabilities
243.10M-1.59%
Total equity
39.51M
Shares outstanding
246.83M
Price to book
9.29
Return on assets
-43.03%
Return on capital
-139.67%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-47.92M-63.82%
Cash from operations
-14.68M-818.71%
Cash from investing
68.20M225.49%
Cash from financing
74.00K-94.73%
Net change in cash
53.94M86.73%
Free cash flow
-31.67M-1,694.94%
About
Founded
2008
Employees
449
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu